Ceftriaxone And Dextrose Injection, Solution
Product Images NDC 0264-3155

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ceftriaxone And Dextrose (NDC 0264-3155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diagram 1 (Ceftriaxone And Dextrose In Duplex 1)

FDA Label Image

2g 50_ml Container Label 3155-11 (Ceftriaxone And Dextrose In Duplex 10)

The text describes CefTRIaxONE and Dextrose Injection that comes in a 50mL duplex container. The container has two chambers that should be mixed before use. The reconstituted solution is for intravenous use only and is sterile/nonpyrogenic. The solution contains Ceftriaxone for injection and Dextrose USP in Water for Injection USP. It should be stored at 20-25°C before reconstitution and protected from light afterward. It should be used within 24 hours if stored at room temperature or within seven days if stored under refrigeration. The container should be checked for minute leaks before administration, and if leaks are found, the container should be discarded. The product does not contain natural rubber latex, PVC, or DEHP. The NDC number for the product is (01)10302643155114.*

FDA Label Image

Drug Chamber Label (Ceftriaxone And Dextrose In Duplex 11)

This text is a label for a drug chamber. It instructs the user to discard the unit if the foil strip is damaged, and to visually inspect the drug prior to reconstitution. The user is advised to refer to the package insert for complete directions for reconstitution and administration.*

FDA Label Image

Diagram 2 (Ceftriaxone And Dextrose In Duplex 2)

FDA Label Image

Diagram 3 (Ceftriaxone And Dextrose In Duplex 3)

FDA Label Image

Diagram 4 (Ceftriaxone And Dextrose In Duplex 4)

FDA Label Image

Diagram 5 (Ceftriaxone And Dextrose In Duplex 5)

FDA Label Image

Ceftriaxone Molecular Formula (Ceftriaxone And Dextrose In Duplex 6)

FDA Label Image

Dextrose Molecular Formula (Ceftriaxone And Dextrose In Duplex 7)

FDA Label Image

1g 50_ml Container Label 3153-11 (Ceftriaxone And Dextrose In Duplex 8)

Ceftriaxone for Injection and Dextrose Injection is a medication prescribed for intravenous use only. The contents of both chambers need to be mixed before use. The product is sterile, non-pyrogenic, and isotonic. The instructions for reconstitution are included. The reconstituted solution must be used within 7 days. The product should be stored at room temperature or under refrigeration. Additives should not be introduced into this container, and it should not be used in a series connection. Leaks may cause sterility issues. The product does not contain natural rubber latex, PVC or DEHP. It is made in the USA and Italy. The container has a Controlled Room Temperature (CRT) label. The lot number and NDC number are available.*

FDA Label Image

Drug Chamber Label (Ceftriaxone And Dextrose In Duplex 9)

This is a label from a drug chamber that warns to discard the unit if the foil strip is damaged. It instructs to peel the foil strip only when ready for use and to visually inspect the drug before reconstitution. It also mentions to see the package insert for complete directions for reconstitution and administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.